Today, the U.S. Food and Drug Administration allowed genetic testing service 23andMe to begin marketing tests designed to provide you with risk information regarding several genetic conditions, including Parkinson’s disease, late-onset Alzheimer’s disease, and Celiac disease.
The Personal Genome Service Genetic Health Risk test runs for $200, and looks for genetic variants associated with 10 major diseases.
The idea is that you take the test and learn you have a predisposition to certain conditions, then you can make more educated decisions about your lifestyle choices, take preventative measures, and have more informed discussions with your doctor.
The test looks for genetic variants that are associated with these diseases and conditions:
But as Dr. Jeffry Shuren, director of the FDA’s Center for Devices and Radiological Health, makes clear in the press release, these tests cannot determine your overall risk of developing these conditions, only that you possess the genetic variants that may put you at risk.
And that risk is only one piece of the much larger puzzle.